TRCT
PMD

Tower Research Capital (TRC)’s Psychemedics Corporation PMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,977
Closed -$4.57K – 6122
2024
Q3 		$4.57K Sell
1,977
-1,590
-45% -$3.57K ﹤0.01% 4497
2024
Q2 		$8.63K Buy
3,567
+522
+17% +$1.33K ﹤0.01% 4322
2024
Q1 		$8.92K Buy
3,045
+724
+31% +$2.29K ﹤0.01% 3930
2023
Q4 		$6.87K Buy
2,321
+584
+34% +$1.56K ﹤0.01% 4691
2023
Q3 		$6.9K Buy
1,737
+861
+98% +$3.84K ﹤0.01% 4544
2023
Q2 		$4K Buy
876
+428
+96% +$2.17K ﹤0.01% 5001
2023
Q1 		$3K Buy
448
+96
+27% +$532 ﹤0.01% 5265
2022
Q4 		$2K Buy
352
+303
+618% +$1.79K ﹤0.01% 5455
2022
Q3 		$0 Sell
49
-1,136
-96% -$7.3K ﹤0.01% 6594
2022
Q2 		$7K Sell
1,185
-385
-25% -$2.47K ﹤0.01% 4842
2022
Q1 		$11K Buy
1,570
+981
+167% +$6.94K ﹤0.01% 4228
2021
Q4 		$4K Buy
+589
New +$4.71K ﹤0.01% 5362
2021
Q3 		– Sell
-390
Closed -$3K – 6271
2021
Q2 		$3K Sell
390
-268
-41% -$1.88K ﹤0.01% 4971
2021
Q1 		$4K Sell
658
-454
-41% -$3.01K ﹤0.01% 4820
2020
Q4 		$5K Sell
1,112
-158
-12% -$686 ﹤0.01% 4653
2020
Q3 		$6K Buy
1,270
+1,190
+1,488% +$5.8K ﹤0.01% 4320
2020
Q2 		$0 Sell
80
-168
-68% -$938 ﹤0.01% 5052
2020
Q1 		$2K Sell
248
-174
-41% -$1.47K ﹤0.01% 2657
2019
Q4 		$4K Buy
422
+149
+55% +$1.38K ﹤0.01% 2832
2019
Q3 		$2K Sell
273
-1,270
-82% -$10.8K ﹤0.01% 3759
2019
Q2 		$16K Buy
1,543
+1,298
+530% +$14.7K ﹤0.01% 2310
2019
Q1 		$3K Sell
245
-44
-15% -$756 ﹤0.01% 3331
2018
Q4 		$5K Sell
289
-176
-38% -$3.03K ﹤0.01% 2954
2018
Q3 		$9K Sell
465
-4,279
-90% -$85.2K ﹤0.01% 2848
2018
Q2 		$91K Buy
4,744
+4,012
+548% +$81.3K 0.01% 1496
2018
Q1 		$16K Buy
+732
New +$15.2K ﹤0.01% 2282
2017
Q4 		– Sell
-4,238
Closed -$78K – 4128
2017
Q3 		$78K Buy
+4,238
New +$93.3K 0.01% 1589
2016
Q4 		– Sell
-2,299
Closed -$46K – 4503
2016
Q3 		$46K Buy
2,299
+1,507
+190% +$27.9K ﹤0.01% 1196
2016
Q2 		$11K Buy
792
+320
+68% +$4.45K ﹤0.01% 2754
2016
Q1 		$6K Buy
472
+402
+574% +$4.61K ﹤0.01% 2579
2015
Q4 		$1K Sell
70
-23
-25% -$251 ﹤0.01% 4193
2015
Q3 		$1K Sell
93
-895
-91% -$10.4K ﹤0.01% 3700
2015
Q2 		$15K Buy
+988
New +$15.4K ﹤0.01% 2367
2015
Q1 		– Sell
-329
Closed -$5K – 5034
2014
Q4 		$5K Buy
+329
New +$4.78K ﹤0.01% 2754
2014
Q3 		– Sell
-300
Closed -$4K – 4974
2014
Q2 		$4K Sell
300
-579
-66% -$8.79K ﹤0.01% 3045
2014
Q1 		$15K Sell
879
-521
-37% -$8.64K ﹤0.01% 2204
2013
Q4 		$21K Sell
1,400
-90
-6% -$1.24K ﹤0.01% 2294
2013
Q3 		$20K Buy
1,490
+652
+78% +$8.1K ﹤0.01% 2690
2013
Q2 		$9K Buy
+838
New +$9.42K ﹤0.01% 2479

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
SMP
Santa Monica Partners Palm Beach Gardens, Florida $179M AUM 19.18% 1-Year Est. Return

Tower Research Capital (TRC)'s PMD Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 1,977 shares — an estimated $4.57K sold.

Tower Research Capital (TRC) first reported a position in PMD in Q2 2013 and held it in 39 quarters. The position peaked at $91K in Q2 2018. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,977 Psychemedics Corporation shares in Q4 2024, an estimated $4.57K.
  • Tower Research Capital (TRC) first reported a position in Psychemedics Corporation in Q2 2013 and held it in 39 quarters.
  • Tower Research Capital (TRC)'s Psychemedics Corporation position peaked at $91K in Q2 2018.
  • 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.